BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12575220)

  • 1. [Molecular conformation and expression efficiency in the hepatocyte targeting gene drug].
    Lu FG; Liu XW; Ou Yang CH
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):9-12. PubMed ID: 12575220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the molecular conformation of a hepatocyte-targeting gene drug in order to improve its expression efficiency in vitro.
    Liu XW; Lu FG; Wu XP; Ouyang CH; Yang DY; You Y; Lian GH
    Chin J Dig Dis; 2005; 6(1):37-42. PubMed ID: 15667557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Targeting delivery effect of galactose receptor-mediated c-myc antisense oligonucleotide on human hepatocellular carcinoma cell line Bel-7402].
    Jiang JW; Zhang Y
    Ai Zheng; 2004 Nov; 23(11):1288-93. PubMed ID: 15522175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoma-targeted gene delivery using a tumor cell-specific gene regulation system combined with a human liver cell-specific bionanocapsule.
    Kang JH; Oishi J; Kim JH; Ijuin M; Toita R; Jun B; Asai D; Mori T; Niidome T; Tanizawa K; Kuroda S; Katayama Y
    Nanomedicine; 2010 Aug; 6(4):583-9. PubMed ID: 20138242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [RNA interference-mediated silencing of MAT 2A gene attenuates growth and induces apoptosis of hepatoma cells].
    Liu QY; Liu ZS; Wu KL; Zhu Y
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):335-8. PubMed ID: 15918965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
    Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
    Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constructing the eukaryotic expression vector to study preliminarily the functions of hammerhead ribozyme targeting base excision repair gene HOGG1.
    Zhang ZZ; Zhang Q; Wu M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):165-70. PubMed ID: 16608066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nanoparticle-mediated endostatin gene therapy targeting hepatocellular carcinoma utilizing heat-inducible promoter].
    Zhou JJ; Chen RF; Li ZH; Zhou QB; Tang QB; He XY; Lu HW; Guo N
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):795-9. PubMed ID: 19595115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
    Chen L; Altmann A; Mier W; Eskerski H; Leotta K; Guo L; Zhu R; Haberkorn U
    J Nucl Med; 2006 May; 47(5):854-62. PubMed ID: 16644756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting specificity and pharmacokinetics of asialoorosomucoid, a specific ligand for asialglycoprotein receptor on hepatocyte.
    Yang DY; Ouyang CH; Lu FG; Liu XW; Huang LQ
    J Dig Dis; 2007 May; 8(2):89-95. PubMed ID: 17532821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro gene therapy of hepatocellular carcinoma using replication-defective and tumor-specific replication-competent adenovirus carrying interleukin-12 gene].
    Wang XH; Yang JM; Cui ZF; Wang WG; Wu MC; Qian QJ
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):581-4. PubMed ID: 15634515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD80 transfected human hepatocellular carcinoma cells activate cytotoxic T lymphocytes to target HCC cells with shared tumor antigens.
    Chan RC; Xie Y
    Oncol Rep; 2004 Aug; 12(2):435-42. PubMed ID: 15254713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution and metabodynamics of hepatocyte targeting vector molecules in vivo].
    Ouyang CH; Lu FG; Yang DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):26-8. PubMed ID: 12934389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].
    Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ
    Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma.
    Leng J; Zhang L; Yao H; Cao X
    Chin Med J (Engl); 2003 Oct; 116(10):1475-9. PubMed ID: 14570604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicide gene therapy of hepatocellular carcinoma and delivery procedure and route of therapeutic gene in vivo.
    Sun XY; Wu ZD; Hu JB
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):373-7. PubMed ID: 14607709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of recombinant adenoviral vector carrying human tissue inhibitor of metalloproteinase-1 gene and its expression in vitro.
    Xia D; Yan LN; Tong Y; Wang XP; Zhang MM; Zhao LY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):259-64. PubMed ID: 15908326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.